Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q89849344 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241120235915.0 | ||
| 008 | 241120nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q89849344 | ||
| 024 | ‡a 0000-0001-6117-9022 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q89849344 | ||
| 100 | 0 | ‡a Li Di ‡c researcher ‡9 en | |
| 400 | 0 | ‡a Li Di ‡c onderzoeker ‡9 nl | |
| 670 | ‡a Author's Clearance in Drug Design | ||
| 670 | ‡a Author's Dasotraline as a selective cytochrome 2B6 inhibitor for reaction phenotyping | ||
| 670 | ‡a Author's Dose Predictions for Drug Design | ||
| 670 | ‡a Author's In vitro and in vivo methods to assess pharmacokinetic drug- drug interactions in drug discovery and development | ||
| 670 | ‡a Author's Quantum Mechanics Modeling of Oxetanes as Epoxide Hydrolase Substrates | ||
| 670 | ‡a Author's Relevance of Half-Life in Drug Design. | ||
| 670 | ‡a Author's The Impact of Low Temperature on Fraction Unbound for Plasma and Tissue | ||
| 670 | ‡a Author's The Role of Alcohol Dehydrogenase in Drug Metabolism: Beyond Ethanol Oxidation | ||
| 909 | ‡a (orcid) 0000000161179022 ‡9 1 | ||
| 919 | ‡a clearanceindrugdesign ‡A Clearance in Drug Design ‡9 1 | ||
| 919 | ‡a dasotralineasaselectivecytochrome2b6inhibitorforreactionphenotyping ‡A Dasotraline as a selective cytochrome 2B6 inhibitor for reaction phenotyping ‡9 1 | ||
| 919 | ‡a dosepredictionsfordrugdesign ‡A Dose Predictions for Drug Design ‡9 1 | ||
| 919 | ‡a invitroandinvivomethodstoassesspharmacokineticdrugdruginteractionsindrugdiscoveryanddevelopment ‡A In vitro and in vivo methods to assess pharmacokinetic drug- drug interactions in drug discovery and development ‡9 1 | ||
| 919 | ‡a quantummechanicsmodelingofoxetanesasepoxidehydrolasesubstrates ‡A Quantum Mechanics Modeling of Oxetanes as Epoxide Hydrolase Substrates ‡9 1 | ||
| 919 | ‡a relevanceofhalflifeindrugdesign ‡A Relevance of Half-Life in Drug Design. ‡9 1 | ||
| 919 | ‡a impactoflowtemperatureonfractionunboundforplasmaandtissue ‡A The Impact of Low Temperature on Fraction Unbound for Plasma and Tissue ‡9 1 | ||
| 919 | ‡a roleofalcoholdehydrogenaseindrugmetabolismbeyondethanoloxidation ‡A The Role of Alcohol Dehydrogenase in Drug Metabolism: Beyond Ethanol Oxidation ‡9 1 | ||
| 996 | ‡2 ISNI|0000000117079577 | ||
| 996 | ‡2 DNB|1239186673 | ||
| 996 | ‡2 DNB|1056087862 | ||
| 996 | ‡2 DNB|1263015298 | ||
| 996 | ‡2 BNC|981058522589806706 | ||
| 996 | ‡2 DNB|1074731522 | ||
| 996 | ‡2 ISNI|0000000079290266 | ||
| 996 | ‡2 ISNI|0000000479735797 | ||
| 996 | ‡2 DNB|1122756887 | ||
| 996 | ‡2 DNB|130817604X | ||
| 996 | ‡2 DNB|1232031461 | ||
| 996 | ‡2 ISNI|0000000398291741 | ||
| 996 | ‡2 DNB|1336008113 | ||
| 996 | ‡2 RERO|A013991338 | ||
| 996 | ‡2 CYT|AC000647843 | ||
| 996 | ‡2 DNB|1080512357 | ||
| 996 | ‡2 ISNI|0000000080029065 | ||
| 996 | ‡2 J9U|987007373211105171 | ||
| 996 | ‡2 ISNI|0000000080904878 | ||
| 996 | ‡2 JPG|500125659 | ||
| 996 | ‡2 ISNI|0000000063607388 | ||
| 996 | ‡2 DNB|1277786194 | ||
| 996 | ‡2 DNB|1146599382 | ||
| 996 | ‡2 NTA|344678369 | ||
| 996 | ‡2 DNB|123224195 | ||
| 996 | ‡2 ISNI|0000000106555558 | ||
| 996 | ‡2 DNB|1031820965 | ||
| 996 | ‡2 LC|n 2007184005 | ||
| 996 | ‡2 CYT|AC000000311 | ||
| 996 | ‡2 NUKAT|n 2008106181 | ||
| 996 | ‡2 DNB|1347320393 | ||
| 996 | ‡2 ISNI|0000000081359138 | ||
| 996 | ‡2 BIBSYS|8032352 | ||
| 996 | ‡2 DNB|1065751001 | ||
| 996 | ‡2 RERO|A000104605 | ||
| 996 | ‡2 DNB|1056083891 | ||
| 996 | ‡2 BNF|17850260 | ||
| 996 | ‡2 BNF|12518843 | ||
| 996 | ‡2 LC|n 85239626 | ||
| 996 | ‡2 SUDOC|184613892 | ||
| 996 | ‡2 CAOONL|ncf11458978 | ||
| 996 | ‡2 J9U|987007325557905171 | ||
| 996 | ‡2 NKC|xx0175705 | ||
| 996 | ‡2 NTA|101063091 | ||
| 996 | ‡2 DNB|140605754 | ||
| 996 | ‡2 SUDOC|034431942 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
